COVID-19 Hub

As we continue to face a worldwide public health crisis, the Reagan-Udall Foundation is your connection to the latest, science-based information regarding COVID-19 and the products we use, the food we eat, and the medicine we take.

Find COVID-19 Clinical Trials & Expanded Access

Find Clinical Trials and Expanded Access

COVID-19 Lessons Learned

COVID-19 Vaccine Confidence Project

COVID-19 Evidence Accelerator

Updates from the FDA

Monday, October 07, 2024	FDA Authorizes Marketing of First Home Flu and COVID-19 Combination Test Outside of Emergency Use Authorities
Tuesday, September 03, 2024	La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente
Friday, August 30, 2024	FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants
Thursday, August 22, 2024	FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Critical information on medical response and food/veterinary safety

Find COVID-19 Clinical Trials & Expanded Access

COVID-19 Lessons Learned

COVID-19 Vaccine Confidence Project

COVID-19 Evidence Accelerator

Updates from the FDA

Subscribe for updates from the Reagan-Udall Foundation for the FDA